Workflow
J&J(JNJ)
icon
Search documents
Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Businesswire· 2025-12-08 21:25
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 44 Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Management will participate in a Fireside Chat at 11:15 a.m. Eastern Time. The audio webcast replay will be available approximately 48 hours after the webcast. thth A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be ava ...
Can J&J Offset Stelara LOE, MedTech China and Legal Headwinds in 2026?
ZACKS· 2025-12-08 17:11
Key Takeaways J&J is grappling with Stelara biosimilar setbacks, Medicare changes and ongoing talc litigation.Stelara sales fell sharply in 2025 amid biosimilar launches and Medicare Part D redesign impacts.J&J projects stronger 2026 growth driven by key drugs, new launches and improving MedTech momentum.Johnson & Johnson (JNJ) faces several challenges, like potential losses from expiring drug patents, ongoing legal battles related to its talc powder and broader macroeconomic uncertainties. Here, we discuss ...
If You Bought 10 Shares of Johnson & Johnson 10 Years Ago, You’d Have This Much Today
Yahoo Finance· 2025-12-08 15:07
Hindsight is always 20/20, and nowhere is this more evident than in the stock market. But that doesn’t stop investors from trying to determine what they would have made if they had actually invested in a stock they were considering. With this in mind, if you had bought 10 shares of Johnson & Johnson (JNJ) stock 10 years ago, this is how much it would be worth today. Check Out: I Got Rich Investing — These Lessons for Beginners Could Lead To $1 Million Net Worth Read Next: 6 Safe Accounts Proven To Grow Yo ...
Eli Lilly, Pfizer Among 19 Drugs Approved for China's Commercial Health Insurance
International Business Times· 2025-12-08 13:07
China has approved 19 innovative medicines — including major treatments from Eli Lilly, Pfizer, and Johnson & Johnson — for its first commercial health insurance drug catalog, creating a new pathway for companies to sell advanced therapies at better prices.The announcement was made Sunday in Guangzhou, marking a major shift in how China plans to support costly drugs that are too expensive for its state insurance program.The new list includes medicines for cancer, Alzheimer's disease, and rare genetic condit ...
Wall Street Breakfast Podcast: IBM Eyes Another AI Deal (undefined:IBM)
Seeking Alpha· 2025-12-08 12:15
brunocoelhopt/iStock Editorial via Getty Images Listen below or on the go on Apple Podcasts and Spotify IBM will reportedly pay $11B for the data streaming company. (0:15) Lilly, Pfizer, J&J in China’s private insurance catalog. (1:05) White House rolling out $12B in aid for farmers. (2:06) IBM (IBM) is in advanced negotiations to acquire Confluent (CFLT) — a real-time data infrastructure company — in a deal valued at around $11 billion, according to the Wall Street Journal. The move would support I ...
礼来(LLY.US)、强生(JNJ.US)与辉瑞(PFE.US)拓展中国市场:旗下创新药物纳入首版商保目录
智通财经网· 2025-12-08 04:16
智通财经APP获悉,礼来(LLY.US)、辉瑞(PFE.US)和强生(JNJ.US)在中国首个创新药物目录中占据了一 席之地,开辟了新的市场渠道,提高了昂贵尖端疗法的销售前景。在广州白云区举行的2025创新药高质 量发展大会上,共有19种创新药被列入医保报销清单,这些药品价格过高,不属于国家医保范围,但建 议纳入商业医保。这些药品涵盖多种疾病,包括癌症、阿尔茨海默病以及罕见遗传性疾病。 随着中国人口老龄化,对癌症、糖尿病、痴呆症等疾病治疗药物的需求日益增长,将这些药物纳入医保 体系或可减轻国家医保的负担。逐步过渡到商业医保报销模式,预计也将使国内外制药企业能够以更高 的价格销售药品,从而提升利润率。长期以来,由于国家医保体系要求大幅降价,制药企业的利润率一 直受到抑制。 政府并未立即公布平均折扣幅度。此前媒体报道称,折扣幅度在15%至50%之间——低于通常纳入国家 报销药品目录(NRDL)所需的60%折扣。 据大和资本市场分析师Wilfred Yuen称,最终入选的药物——从进入最终谈判的24种药物中选出——成 功率并不高,这表明监管机构在实施的第一年采取了谨慎的态度。该分析师称:"最终的影响将因产品 和公司 ...
美国医疗:2026医院展望调查-2026 Hospital Outlook Survey
2025-12-08 00:41
December 2, 2025 11:00 AM GMT US Healthcare Research | North America 2026 Hospital Outlook Survey Our AlphaWise survey of 100 US-based hospital executives supports a steady environment for medical devices into '26. The survey provides increased confidence in the continuation of capex spending momentum with some prioritization shifts, improving utilization and stable medical acuity. M We conducted an AlphaWise survey of 100 hospital executives in November 2025, representing a total of ~39,500 hospital beds ( ...
15 Top Colleges For Launching Your Career
Forbes· 2025-12-07 11:30
Core Insights - The article discusses the challenges faced by recent college graduates in securing employment, particularly in light of rising unemployment rates and the impact of artificial intelligence on entry-level jobs. It emphasizes the importance of cooperative education programs and internships in enhancing job prospects for students [1][3][4]. Employment Landscape - The unemployment rate for recent college graduates aged 22 to 27 is 4.8%, higher than the overall worker unemployment rate of 4% and significantly higher than the 7.4% for young workers without degrees [3]. - A private survey indicates that only 30% of 2025 college graduates had secured full-time jobs related to their degrees by summer, a decrease from 41% for the 2024 graduates [3]. - The National Association of Colleges & Employers found that 2025 graduates received an average of 0.78 job offers each, down from 1.13 for the class of 2023 [3]. Shift in Student Priorities - Current high school seniors are increasingly focused on the return on investment of their college education, prioritizing post-graduation employment opportunities over traditional college experiences [5]. - The article highlights a new list of 15 colleges that excel in preparing students for the workforce, emphasizing their commitment to internships and cooperative education [6]. Cooperative Education Programs - Only about 25 of the top 500 colleges offer co-op programs that integrate full-time work experience into their curriculum, with only two schools requiring all students to complete a co-op to graduate [7]. - Schools with strong co-op programs report higher rates of employment for graduates, with a study showing that students who completed internships were nearly 50% less likely to be underemployed five years after graduation [8]. Internship Competition - The average number of applications per internship posting has more than doubled in the past year, indicating increased competition for available positions [9]. - Despite the rising competition, 95% of jobs posted on Handshake are paid opportunities, and many schools provide financial support for students undertaking unpaid internships [9]. Salary Disparities - Graduates from technology and business-focused schools tend to earn significantly higher salaries compared to those from liberal arts colleges, with median salaries for graduates from top institutions reaching as high as $100,500 three years after graduation [10]. Career Preparation Strategies - The 15 colleges highlighted employ various strategies to enhance career readiness, including mandatory internships, extensive career training, and partnerships with employers [11]. - For instance, Arizona State University offers virtual classes on personal branding and networking, while Babson College emphasizes experiential learning through applied projects [12][13]. Notable Institutions - Northeastern University is recognized for its extensive co-op program, with 70% of students completing two co-ops before graduation, leading to an 82% employment rate within nine months of graduation [20]. - Kettering University requires all students to participate in co-ops, resulting in graduates accumulating 2.5 years of work experience by the time they graduate [19]. - The University of Washington utilizes advanced career preparation tools, with 71% of students completing internships before graduation [26].
2025国谈落地:双管齐下,从“用得上”走向“用得起”
上海市卫生和健康发展研究中心主任金春林对21世纪经济报道记者表示,2025年医保目录新增114种药品,其中一类创新药高达50种,占比近 44%,这一比例颇为可观,显著反映了创新药物在医保目录中的比重逐年攀升。这一变化无疑彰显了医保政策对"真支持创新、支持真创新、支持 差异化创新"的坚定承诺。 (原标题:2025国谈落地:双管齐下,从"用得上"走向"用得起") 21世纪经济报道记者 季媛媛、闫硕 2026年1月1日起,中国医保目录将迎来历史上规模最大的一次创新药扩容。 12月7日,国家医保局披露,经相应程序,本次目录调整新增114种药品,其中50种1类创新药,同时调出了29种临床没有供应或可被其他药物更好 替代的药品(其中9种尚有相同治疗主成分的其他剂型在目录内,不减少目录编号)。本次调整后,目录内药品总数增至3253种,其中西药1857 种、中成药1396种,肿瘤、慢性病、精神疾病、罕见病、儿童用药等重点领域的保障水平得到明显提升。新版医保目录将于2026年1月1日起正式 实施。 "在医保管理中,如何妥善平衡创新药物的临床价值、企业收益与基金的可持续性,是一个复杂的问题。其中,创新药物的定价策略尤为关键,即 ...
Global Developments: Geopolitical Shifts, Tech Rivalries, and Fiscal Pressures Emerge
Stock Market News· 2025-12-07 06:08
Key TakeawaysUS Attorney General Pam Bondi has reportedly directed the FBI to compile a list of Americans identified as potential "extremists," based on a leaked memo, sparking significant debate over civil liberties and domestic surveillance.Chinese phonemakers are actively seizing market share from Apple (AAPL) due to perceived struggles in the iPhone maker's artificial intelligence development, signaling a competitive shift in the global tech sector.Major pharmaceutical companies Eli Lilly (LLY), Pfizer ...